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Abstract 
Reparative medical techniques, in conjunction with existing and emerging tissue 
adherents and sealants, offer practicing physicians a wide variety of tools to improve the 
functionality, performance, and safety of surgical interventions. Carboxymethylcellulose (CMC) 
is a plant-derived polymer that is cytocompatible, biocompatible, biodegradable, and 
inexpensive. The need for a non-toxic but strongly adherent material motivated the development 
of an injectable bioadhesive system containing CMC modified with functional methacrylate and 
aldehyde groups that could potentially be used as an annulus fibrosus sealant or as a supplement 
to existing wound closure materials. After modification, the polymer was characterized via NMR 
spectroscopy, Schiff’s base reaction, and size exclusion chromatography with multi-angle light 
scattering (SEC-MALS). The adhesive strength of the material was determined by lap shear 
testing with porcine skin. 
 High molecular weight and medium molecular weight methacrylated dialdehyde 
carboxymethylcellulose (MeDCMCHV & MeDCMCMV) were engineered and MeDCMCHV was 
combined with low viscosity methacrylated CMC (MeCMCLV1) to produce an adhesive 
hydrogel. The percent oxidation and methacrylation was measured to be 21.1 ± .84 % and 49.0% 
for MeDCMCHV2. The percent methacrylation of MeCMCLV1 was determined to be 30.6%. 
Various ratios of MeDCMCHV to MeCMCLV were tested via lap shear testing and the best 
combination possessed a shear adhesive strength of 6.022 ± 1.456 kPa. The dispersity index (Đ) 
was calculated to be 1.93 for MeDCMCHV and 2.94 for MeDCMCMV. The creation of an 
adhesive from MeDCMCHV will provide a foundation for the development of cellulose-based 
annulus fibrosus sealant with stronger adhesive strength and highly tunable properties such as 
swelling-ratio, pore size, and degradation profile. 
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Chapter 1 - Introduction 
1.1 Repairing Intervertebral Disc Injury 
The intervertebral disc (IVD) is a tissue located between the vertebral bodies of the spine, 
keeping them spaced within a tolerant range. It is composed of two macroscopic regions, the 
nucleus pulposus (NP), and the annulus fibrosus (AF)
1
. The viscous, gelatinous structure of the 
NP allows it to bear large compressive loads through pressurization and transfer of the load to 
the AF and cartilaginous endplate (CEP)
2,3
. The NP matrix is composed of four constituents, 
water, collagen, proteoglycans and cells. The AF surrounds the NP with multiple cross-ply 
laminated structures with anywhere from 10 to 25 lamellae and is composed of water, collagen, 
proteoglycans, and cells. Degeneration of the annulus fibrosus due to aging and the presence of 
advanced glycation end-products lead to a change in the anisotropic and nonlinear behaviors of 
the tissue in compression, resulting in an increase in the elastic modulus in compression and a 
decrease in tensile strength in stretch
4,5
. The loss of CEP integrity also leads to the loss of NP 
pressurization and the unsustainable shift of compressive load bearing from the NP to the AF
6
.  
In the general population the prevalence of lower back pain is estimated to be 15% to 
30% with individuals 45 to 65 years of age being at the greatest risk
7,8
. Discogenic back pain is 
pain that arises from the degeneration or disc injury. The treatment of discogenic back pain often 
involves techniques which are highly invasive including lumbar fusion and discectomy, which 
are often successful in alleviating the pain associated with pathologies of the IVD
9–11
. The 
treatments for back pain that exist today do not tackle the restoration of biomechanical properties 
of the IVD after injury. In discectomy in particular, when the NP material is removed, the 
compressive load on the IVD is transferred to the AF resulting in abnormal loading which 
increases the possibility for more annular defects, re-herniation, and pain
12
. An annular defect via 
needle puncture was shown to have a drastic impact on the maximum strain of AF fibers in 
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locations near and away from the site of injury as demonstrated by the strain map in Figure 1-1. 
Therapies being explored have shown that biomaterials may be used to replace damaged or 
missing NP material
14–17
. In addition to materials for NP replacement, a suitable AF replacement 
or sealant should be explored. A cellulose-based bioadhesive/sealant may provide the adhesion 
and cohesion suitable for the containment of native NP tissue or engineered NP replacement 
technologies.  
 
1.2 Surgical Practice 
Hemostats, sealants, and adhesives are gaining popularity and acceptance in surgical 
practice in the United States as a means of achieving maximal wound closure. A hemostat is a 
surgical tool or a chemical agent at the disposal of a surgeon to stop bleeding through mechanical 
compression or blood coagulation. Tissue sealants create an impenetrable barrier sealing the 
tissue. Adhesives are self-polymerizing solutions that adhere to tissues. Surgical glues and 
Figure 1-1. (Left) Strain map of control, (Right) Strain map of needle punctured 
sample with white arrows indicating areas of increased strain
13
. 
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hemostats are used in order to create a mechanical barrier where there is bleeding present and 
help to enhance coagulation
18
. In 2009 there were 10 million surgical and nonsurgical cosmetic 
procedures performed, 2.5 million of which were botulinum toxin injections and 1.3 million 
hyaluronic acid filler injections
19
. While 85% of the cosmetic procedures performed are non-
surgical, there is still a market for cosmetic and non-cosmetic surgeries requiring wound closure. 
Outcomes of patients requiring wound closure are dependent on wound infection, restoration of 
function, and optimal cosmetic results
20
. As government regulators, hospital administrations, and 
patients desire more minimally invasive procedures, engineering solutions are in demand to help 
promote the restoration of mechanical and cosmetic properties of tissues and minimizing blood 
loss
21
. 
 
 1.2 Sutures, staples, and adhesive strips 
Sutures have been used for millennia as a means of closing wounds. Recent technological 
innovations have increased their effectiveness
22
. When selecting the ideal suture it is important to 
consider the age of the patient, the location of the wound, the presence or absence of infection, 
and the surgeon’s personal experience and preference of materials, as some materials are more 
difficult to handle than others
23
. The physical characteristics include their method of absorption, 
composition, configuration, and surface topology. Suture absorption is defined as the loss of 
most of its tensile strength within 60 days of tissue implantation
22
. Material compositions range 
from natural materials like Catgut, derived from cow or sheep intestinal submucosa and silk
22–24
, 
to synthetic materials including nylon, polypropylene, poly(glycol terephthalate), and 
poly(butylene terephthalate); each of these materials having a unique tissue reactivity, tensile 
strength, and handling
22,23
. While sutures are the gold standard of wound closure, they present 
cosmetic issues because the intact surrounding tissue is subject to damage. Surface stitch 
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configuration and the type of surface stitch plays a role in the amount of scarring that occurs as a 
result of the wound and the suture
22,23
. The use of sutures after annular repair has been shown to 
decrease the rate of disc degeneration as well as promote the restoration of biomechanical 
properties, however, AF replacement technologies still need to be explored that help reverse disc 
degeneration and improve the mechanical function of the intact AF tissue
25,26
.Skin staples are 
primarily important because they can be applied to a wound quickly. They are ejected from a 
device which significantly reduces the time required to fully close the wound and they are 
sometimes used to temporarily position skin edges together before suturing
23
. Staples come in 
primarily two materials, a non-absorbable stainless steel, the highest tensile strength wound 
closure material, and an absorbable u-shaped material of primarily of poly(lactide) and a 
secondary component of poly(glycolide). Absorbable sutures retain 40% of their strength at 14 
days and completely absorb over the course of months
23
. The biggest disadvantage of using 
sutures and staples is that they have to be sewn in which creates damage to the tissue requiring 
closure.  
Adhesive strips are often used in conjunction with sutures or other closure materials 
because they help maintain the integrity of the epidermis which results in less tension to the 
wound and sutures
23
. They are also used in the retention of wound closure after the removal of 
sutures. Adhesive strips suffer from the lack of tissue integration as they do not adhere or do not 
remain intact in moist areas, areas of high movement, and areas of high tension making them 
unsuitable for a wide variety of applications
18
. Biomaterials being explored must be easy to use, 
rapid, painless, cost effective, and provide excellent comesis
23
. 
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Chapter 2 –Clinically Available Materials for Wound Closure 
2.1 FDA-Approved Adhesive Materials 
 The Food and Drug Administration (FDA) has approved many materials for use as 
hemostats, sealants, adhesives, and postoperative adhesion prevention agents. These materials 
include synthetic polymers, human and bovine-derived polymers, and plant-based polymers
21
. 
Many biomaterials have been exhaustively studied and thus can be a benchmark for performance 
as well as a means of determining what characteristics are desirable for biomaterials to be 
developed for AF repair.  
 
2.2 PEG Sealants 
 Biosynthetic materials derived from synthetic polymers have been functionalized with 
biological constituents in a manner that optimizes them for biomedical implantation. Coseal 
(Baxter, Fremont California) is a mixture of multifunctional polyethylene glycol (PEG) 
macromers contained in an aqueous hydrogen chloride and sodium phosphate-sodium carbonate 
solution. Coseal is used to mechanically seal areas of leakage around blood vessels. Coseal 
swells up to 400 percent which introduces increased risk for complications in closed spaces
27,28
. 
Duraseal Xact (Covidien, Mansfield, MA), a modified version of a previously FDA-approved 
synthetic spinal sealant Duraseal (Coviden), has been recently approved by the FDA
21
. This 
material is used in conjunction with sutures in dural repair to create a watertight seal of the dural 
matter, reducing the risk of cerebrospinal fluid (CSF) leak and inhibiting the formation of scar 
tissue
29
. This material consists of a PEG polymer with tri-lysine amine as well as FD&C blue 
No. 1 dye in order to demarcate boundaries and assist the surgeon with placement
18
. The lower 
molecular weight of the PEG in Duraseal Xact reduces the swelling to reduce the possibility of 
nerve compression. Duraseal Xact has been shown to swell from 50 to 100 percent, a significant 
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improvement over Duraseal, but still presents the possibility for complications due to 
swelling
18,28
. Rapid polymerization of this material also reduces the risk of CSF leakage after 
surgery, thereby increasing the overall safety and effectiveness of the product
30,31
.  
 
2.3 Fibrin-based sealants 
FDA-approved Tisseel (Baxter, Westlake Village, CA), Evicel (Johnson& Johnson), and 
the CryoSeal systems (ThermoGenesis Corp., Rancho Cordova, CA) are commercially available 
fibrin sealants that are used in various hemostatic, sealant and adhesive capacities
21,32
. 
Commercial agents like Tisseel contains elements that prolong and ensure the stability of the clot 
such as the serine protease inhibitor aprotinin, which works to limit the degradative effects of 
plasmin, kallikrein, and trypsin
33
. The benefits of fibrin-based sealants are that they quickly cure, 
are biocompatible, and biodegradable. Fibrin-based sealants like Tisseel and Evicel are derived 
from human pooled plasma fibrinogen and thrombin, which introduces the possibility of 
transferring blood borne diseases including human immunodeficiency virus, hepatitis, parvovirus 
B19, as well as prions
34,35
. Manufacturers have employed multiple strategies in order to reduce 
the risk of disease transmission including donor screening, testing, and pathogen reduction 
strategies. In the last 20 years there are no reports of HIV or hepatitis transmission as a result of 
fibrin based sealants, however, there is documentation of the transmission of parvovirus B19 as a 
result of fibrin sealants
35,36
. The CryoSeal system has circumvented the risk of contracting 
diseases from allogeneic plasma pools through the production of an automated device that 
produces several units of fibrin sealant from 450 ml of the patient’s blood preoperative 
preparation.
37
 While fibrin sealants and adhesives may be biocompatible and commonly used in 
surgical practice, their relatively low adhesion to tissue make them a poor choice for true 
bioadhesive applications such as for AF repair
38
. Additionally, the risk of host enzyme 
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degradation makes fibrin-based sealants unlikely for use in long-term applications such as an AF 
sealant.  
 
2.4 Cyanoacrylate-based sealants and adhesives 
Omnex (Ethicon, Inc., Somerville, NJ), a cyanoacrylate-based synthetic surgical sealant, 
is composed of a mixture of 2-octyl cyanoacrylate and butyl lactoyl cyanoacrylate
39
. This 
material is used as a supplement to mechanical closure techniques such as sutures and staples. 
Generally, cyanoacrylates are not approved for internal use. However, the Omnex formulation 
proposes that the release of the formaldehyde degradation product occurs in a slow and safe 
manner over the course of 36 months as to not pose a major risk for cytotoxicity
21
. While 
cyanoacrylate-based sealants may be strongly adhesive in the surgical setting there is great risk 
for injury to the tissue and contamination through adhesion with surgical tools, gloves, and non-
intended tissue targets especially if the surgeon is unable to properly control the application of 
this polymer
21
. Therefore, biomaterials must be explored that meet adhesive requirements but do 
not pose a great risk for injury in the event of surgeon error. 
The FDA has approved multiple cyanoacrylate based adhesives which include 
Dermabond (Johnson & Johnson, Somerville, NJ) Indermil (Covidien, Norwalk, CT) and two 
formulations Histoacryl and Hystoacryl Blue (Tissueseal, Ann Arbor, MI)
18
. These materials 
have been approved for use as an additive to traditional surgical skin closure methods like 
sutures and staples to keep the edges of skin together. The exothermic nature of the reaction as 
well as the toxicity of the degradation products, specifically cyanoacetates and formaldehyde, 
restricts its internal use
34
. Therefore, such adhesives are unlikely to serve as candidate materials 
for AF repair. When used in wound closures, to limit adverse reactions from heat sensitivity and 
discomfort, only thin layers are applied
34
. Additionally, the site of wound closure is of great 
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importance with cyanoacrylate-based adhesives as they are extremely adhesive and extremely 
stiff. These products are not approved for use in areas of high tension, across joints, on mucosal 
surfaces, at mucocutaneous junction or on areas of dense hair growth
18
. 
 
2.5 Albumin and Glutaraldehyde based adhesives 
Bioglue (Cryolife, Kennesaw, GA) is a serum albumin and glutaraldehyde mixture that is 
approved for vascular sealing. The glutaraldehyde cross-links with the amine groups, specifically 
the lysines of albumin and tissue surfaces, creating a tightly cross-linked adhesive
18
. Safety 
concerns have arisen due to potential nerve conduction system injury from glutaraldehyde, local 
tissue necrosis, mutagenicity, abnormalities in calcium metabolism, disease transmission; eye, 
nose, throat, and skin irritation
18
. Glutaraldehyde has been shown to induce cytotoxic effects in 
vitro and in vivo, specifically in lung and liver tissue
28,40
. 
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Chapter 3 – Experimental Materials for Bioadhesion 
As many of the currently FDA-approved materials have been shown to be either 
ineffective in adhesion or deemed to toxic for internal use, many research groups are exploring 
the possibility of modifying materials for the purpose of making them bioadhesive and 
biocompatible. Through the exploration of mechanisms of adhesion as well as material cohesion, 
biomaterials can be tailored to meet the properties of the tissues of interest. 
3.1 Protein and Polysaccharide-Based Materials for Bioadhesion 
Oxidized polysaccharide-based bioadhesives have been investigated in order to address 
some of the disadvantages and limitations of commercially available bioadhesives. These 
materials include but are not limited to dextran
41–43
, alginate
44,45
, and chondroitin sulfate
46
. 
Oxidized polysaccharides have been chosen as materials for bioadhesives because they are 
generally biocompatible, biodegradable, and exhibit superior adhesion strength when compared 
to commercially available non-glutaraldehyde/cyanoacrylate based bioadhesives. The oxidation 
level of the material determines the number of aldehyde groups created and thus the maximum 
adhesive strength of the material can be adjusted to fit specific tissues based on the required 
adhesion strength and protein density. The mechanism by which aldehydes create bonds with 
proteins is through the Schiff base reaction with the terminal ends of proteins or the basic ɛ- 
amino of lysine (demonstrated in Figure 3-1). Given that mammalian skin is a collagenous tissue 
+ 
ɛ-amino of lysine or 
terminal amino acid Aldehyde Schiff base linkage 
Figure 3-1. Schiff Base Formation with Aldehyde and ɛ-amino of Lysine 
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more than 50% of the amino acids occurring in the proteins are glycine and 
proline/hydroxyproline
47
. Mammalian skin is composed of 2.9 ± 0.4% lysine and thus its 
relatively low availability makes it a target for attachment because an adhesive will not 
overwhelm the tissue with crosslinks.  
One downside of increased oxidation is the increased degradation which can lead to the 
loss of mechanical properties. Oxidation levels can be tailored to maximize adhesion and to 
control the rate of polymer degradation. Bioadhesives must not only be capable of adhering 
strongly but also degrading in such a manner that is beneficial to the healing process. Adhesion 
is a balance between different types of molecular interactions including hydrophilic/hydrophobic 
interactions, ionic interactions, and covalent and hydrogen bonding
48
. The modification of 
polysaccharides allows for the creation of materials that can optimize these interactions for 
bioadhesive applications. 
Oxidized urethanized dextran has been proposed as a tissue adhesive when used in 
conjunction with gelatin and polymethacrylate. The study by Wang, Nie, and Yang showed that 
varying the degree of oxidation affected the swelling kinetics, swelling ratio, and adhesion 
strength in a photocrosslinked hydrogel
41
. Additionally a tissue adhesive based on oxidized 
dextran and epsilon-poly-l-lysine was shown to be 13 times more adhesive in tensile shear than 
the fibrin-based glue Bolheal
43
. Powdered aldehyde dextran and epsilon-poly (L-lysine) and 
carboxymethylchitosan/oxidized dextran hydrogels have been investigated as an anti-
postoperative adhesion material and has been shown to decrease the severity of adhesions in a rat 
peritoneal injury model
49,50
. 
Hydrogel systems have been fabricated using oxidized methacrylated alginate and 8-arm 
poly(ethylene glycol) amine (OMA/PEG)
45
. The oxidation of the alginate component created 
dialdehydes distributed along the alginate chains and the methacrylate groups were introduced to 
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allow for photocrosslinking capabilities. By having a dual crosslinking mechanism the polymer 
was able to crosslink via imine bonds between the aldehyde groups and amines on the PEG and 
tissue, in addition to covalently crosslinking methacrylate groups in the presence of a 
photoinitiator. When mechanically tested via a pull apart test and this OMA/PEG hydrogel 
exhibited a mean adhesive strength of 15kPa, which is approximately five times stronger than the 
commercially available fibrin sealant Tisseal
45
. 
Multifunctional chondroitin sulfate (CS) adhesives have been explored for potential 
cartilage tissue biomaterial integration
46
. CS was multifunctionalized with methacrylate and 
aldehyde groups through glycidyl methacrylate and sodium periodate oxidation. The basis of the 
creation of this material was the need for a material that allows for cartilage tissue integration. 
This engineered material was proposed as a means of priming the surface of a tissue so that a 
non-oxidized methacrylated poly (ethylene glycol) diacrylate hydrogel could be used as a 
cartilage tissue replacement. The hydrogel-interface adhesive strength was tested in uniaxial 
tensile and horizontal shear with and without the CS primer solution. With the CS primer, the 
tensile strength was 45 kPa and 2.8 kPa without. With the CS primer, the shear strength was 46 
kPa, and 6.0 kPa without, showing that bioadhesives are capable of optimizing existing strategies 
for tissue engineering
46
. 
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 Fibrin-Genipin hydrogels have also been engineered as a means of repairing large AF 
defects in herniation and disc repair
51,52
. Genipin is a plant-derived crosslinking agent that 
crosslinking proteins by binding amine groups
51
. Genipin crosslinked fibrin hydrogels were 
shown to integrate well into the surrounding AF tissue as seen in Figure 3-2 and partially restore 
mechanical properties of injured intervertebral disc motion segments, showing that biomaterials 
may play a key role in the delivery of relief in those suffering with discogenic back pain
52
. 
 
 
3.2 Cellulosic Materials  
Polysaccharide-based hydrogel systems are being explored for a wide variety of tissue 
engineering applications. One family of polymers of great interest is celluloses, specifically 
carboxymethylcellulose (CMC) and methylcellulose (MC), which are water-soluble derivatives 
Figure 3-2. Repair of annular injury with Fibrin-Genipin hydrogel
52
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of cellulose, the primary structural component of the plant cell wall. CMC and MC are non-toxic, 
biodegradable, inexpensive, and used in a wide variety of industries including food, textiles, 
paper, adhesives, paints, pharmaceutics, and cosmetics
53
. Previous work pertaining to the 
creation and the characterization of CMC-based hydrogels for applications in nucleus pulposus 
cell encapsulation for NP replacement has demonstrated that cellulose may be a suitable material 
for NP replacment
54,55
. Through the esterification of hydroxyl groups to add methacrylate groups 
to the cellulose backbone and by varying the molecular weight of the CMC polymer, hydrogels 
have been previously constructed with tunable properties such as stiffness, pore size, and 
swelling ratio. Cellulose is desirable for in vivo applications because cellulose is not readily 
enzymatically degraded, as cellulase is not present in humans. Covalently crosslinked CMC 
hydrogels have been shown to support the differentiation of a wide variety of cells in vitro 
including human fibroblasts, mesenchymal stem cells
55
, as well as nucleus pulposus cells
14
. At 
low temperature methylcellulose is more water soluble, when the temperature is increased over 
35°C a thermoreversible gel is formed which increases the interaction of the polymer chains as a 
result of hydrophobic interaction
56
. Given its ability to thermally gel, methylcellulose may be 
Figure 3-3. Methylcellulose or Carboxymethylcellulose Backbone 
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used in crosslinked hydrogels as a means of increasing solution viscosity and localizing material 
within a void space. 
 The periodate oxidation of cellulosic materials has been used industrially for various 
applications 
57
. The cleavage of the C2-C3 bond of the 1-4 glucan unit produces a dialdehyde 
which can then be used as intermediates for functionalized cellulose-based materials for tissue 
engineering, drug delivery, or any number of applications unrelated to medicine. Additionally 
these aldehydes can be converted to carboxylic acids, primary alcohols or imines with primary 
imines
58
. Polysaccharides containing aldehydes are being explored as bioadhesives because the 
aldehydes can form imine bonds with amines through the Schiff base reaction and bond to the 
surface of tissues
42,43,59
. The material aldehyde density can be tuned to match the tissue protein 
density such that cytotoxic effects, if any, are limited
59
. Polysaccharides that have been oxidized 
to the dialdehyde form are more readily susceptible to alkaline β-elimination and thus hydrolytic 
degradation
60–63
. By varying the degree of oxidation and methacrylation of the polymer the 
degradation can be tuned to a manner that facilitates the retention of wound closure as well as 
wound healing.  
Oxidized regenerated cellulose (ORC), an absorbable knitted fabric that is flexible and 
adheres readily to bleeding surfaces, has been used as a barrier agent for the prevention of 
adhesion formation
64
. The mechanism of action is thought to be the transformation of the knitted 
cellulose into a gelatinous mass that covers the injured tissue and protects the tissue from the 
formation of adhesions
64
. These data suggest that a hydrogel composed of oxidized cellulose 
may be a suitable agent for the prevention of postoperative adhesions. 
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3.3 Redox-Crosslinked Hydrogels 
 Many materials being explored for potential bioadhesive applications have been 
employed photocrosslinking as a means of initiating hydrogel polymerization. Recently, 
injectable CMC and MC hydrogel systems have been investigated that use redox initiators rather 
than photo initiated polymerization as a method to increase the clinical translatability of the 
materials
65,66
. When human dermal fibroblasts were co-cultured with MeCMC and MeMC gels 
polymerized via redox initiators ammonium persulfate (APS) and N, N, N’, N’-
tetramethylethylenediamine (TEMED) at 10 mM concentration, there was no significant effect 
on the proliferation and viability of these cells at 10 mM initiator concentration
65,66
. 
Additionally, APS and TEMED at concentrations of 25 mM have been shown to support cell 
viability and proliferation in an oligo(poly(ethylene glycol) fumarate) scaffold with encapsulated 
rabbit marrow mesenchymal stem cells and transforming growth factor-1 incorporated into 
gelatin microparticles
67
.  
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Chapter 4 - Proposal 
4.1 Rationale 
 As there is strong evidence that polysaccharide-based materials may be suitable for 
bioadhesive applications such as for AF repair, injectable oxidized CMC hydrogels will be 
investigated as an adhesive and sealant, given that CMC is cytocompatible, biocompatible, 
biodegradable, inexpensive, and proven to work in an injectable system. 
 
4.2 Hypothesis 
CMC can be modified via oxidation and a subsequent methacrylation to produce an 
injectable hydrogel that has tunable adhesive properties by varying the concentration of polymer. 
 
4.3 Proposal 
Dual-modified CMC will be synthesized by the sodium periodate oxidation of CMC and 
the esterification of hydroxyl groups to add methacrylate groups to dialdehyde CMC (DCMC). 
Methacrylated dialdehyde CMC (MeDCMC) will be polymerized via redox initiation to produce 
covalently crosslinked hydrogels. The degrees of methacrylation and oxidation will be 
quantitatively determined via 
1
H-NMR spectroscopy and sodium hydroxide consumption after 
Schiff base reaction, respectively. The dispersity of the material will be characterized via Size 
Exclusion Chromatography-Multi Angle Light Scattering (SEC-MALS). Characterization of 
adhesive strength will be quantified via lap shear pull-apart test with porcine epidermis as a 
model for collagenous soft tissues, such as the AF. In addition, tests on porcine epidermis allow 
for direct comparison of the measured adhesive strength of dual-modified CMC with values of 
existing materials used for skin closure described in the literature. 
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Chapter 5 - Methods & Materials 
5.1 Preparation of Oxidized CMC 
In early experiments involving 250 kDa medium viscosity CMC (CMCMV) (Sigma, St. 
Louis, MO) and 700 kDa high viscosity CMC (CMCHV) (Sigma), the unmodified polymer was 
dissolved in DI water to a final solution concentration of approximately 1% to allow for better 
mixing compared to 2% solutions.  It was determined that the final solution concentration of 1% 
or 2% did not have a significant impact on the degree of oxidation. To prepare DCMC, 10 grams 
of CMC-sodium salt was slowly dissolved in 600 ml of deionized water at 50°C for two hours 
and stirred overnight at 4°C. The following day the beaker was wrapped in aluminum foil and 
the solution was heated to 35°C. Concurrently, 11 grams of sodium periodate (Sigma) was 
dissolved in 400 ml of diH2O in the dark and the periodate solution was added to the CMC. The 
pH of the solution was then adjusted to 3.0 using 1M sulfuric acid and allowed to stir in the dark 
for four hours at 35°C while slightly adjusting the pH to 3.0 as needed using sulfuric acid and 
sodium hydroxide. Special precaution was taken to perform the reaction in the dark because 
periodate solutions exposed to light slowly decompose as a result of the auto-reduction of 
aqueous sodium periodate to form ozone and iodate
68
. After four hours, the oxidation reaction 
was terminated by the addition of ethanol at a 2:1 molar ratio of the initial concentration of 
sodium periodate. The reaction mixture was dialyzed for 3 days against diH2O. The mixture was 
then frozen and lyophilized for 3 days until the product was dry. Samples were stored in the 
freezer at -20C. The frozen product was then used in later experiments with MeCMCLV1 
(synthesized from low viscosity, 90 kDa CMC starting material) or subsequently used to produce 
MeDCMC. 
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5.2 Preparation of Methacrylated Celluloses 
Preliminary experiments involving the oxidation of CMCMV showed that conditions that 
reported high yields in aldehyde content (40-50% oxidation) also yielded a product that was 
visually broken down and mechanically inferior as the material did not gel at a redox initiator 
concentration of 25 mM at weight per volume (w/v) percentages upwards of 20%. Therefore, a 
CMC with a larger molecular weight was chosen as the starting polymer with the basis that a 
larger molecule would produce larger fragments in response to dual modification. To prepare 
MeDCMC, lyophilized DCMCHV was dissolved in DI water to final concentration of 2%. Two 
reaction times were chosen, a one-day, 8-hour short reaction and an extended three-day reaction, 
to compare the effect of methacrylation on the adhesive strength of the material. CMCLV or 
DCMCMV,HV was reacted with methacrylic anhydride in 20-fold excess for a theoretical 
methacrylation of 10% at 4°C while adjusting the pH every 3 to 15 minutes to 8.0 with 5N 
NaOH for 7-8 hours for the short one-day methacrylation. For extended methacrylation 
reactions, the same procedure was followed except the addition of methacrylic anhydride was 
extended over the course of three days with pH adjustments to 8.0 for 10 hours on the first day, a 
second day in the refrigerator at 4°C with no pH adjustments, and pH adjustment to 8.0 for 8 
 
Figure 5-1. Periodate Oxidation of CMC to DCMC 
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hours for the third day at 4°C. Once the reaction was finished, the pH was adjusted to 7.0 with 
1N HCl. The solutions were dialyzed against diH2O for 3 days and lyophilized for 3 days. 
Samples were stored in the freezer at -20°C. 
The degree of methacrylation was assessed via 
1
H-Nuclear Magnetic Resonance (NMR) 
spectroscopy at 500 MHz (Varian Mercury 500, Agilent Technologies). Samples were prepared 
for NMR spectroscopy by dissolving 0.02 g of lyophilized MeDCMC in 20 ml of DI water. The 
solution was then acid hydrolyzed in a round bottom flask by adjusting the pH 2.0 using 1N HCl 
and magnetically stirring the mixture in an 80°C silicone oil bath at 200 rpm for 140 minutes. 
The solution was allowed to cool to room temperature then adjusted to pH 7.0 with 1N NaOH 
and subsequently frozen at -80C and lyophilized for three days. After lyophilization the material 
was dissolved in D2O and NMR spectroscopy was performed. 
Figure 5-2. Synthesis of Methacrylated Dialdehyde Carboxymethylcellulose 
 
5.3 Determination of aldehyde content 
The aldehyde content was determined by converting DCMC or MeDCMC to an oxime 
via the Schiff’s base reaction with hydroxylamine hydrochloride as carried out by Li et al53. The 
Schiff’s base reaction was carried out by dissolving three portions of DCMC or MeDCMC 
weighing 0.25 g in separate beakers containing 12.5 ml of diH2O. In parallel, 40 ml of a solution 
 
+ 
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of 0.72 mol/L hydroxylamine hydrochloride (HAHC) was prepared and all the solutions were 
adjusted to pH 5 with 1M NaOH or 1M HCl. After pH adjustment, 10 ml of the HAHC solution 
was added to each of the DCMC solutions and the mixture was stirred for 4 hours in a 
thermostatic water bath at 40°C. After 4 hours the samples were immediately titrated with 1M 
NaOH for the release of HCl until the pH was adjusted to 5. The amount of NaOH required in 
liters was recorded as Vc. The same procedure was performed in triplicates of 12.5 ml of a 2% 
solution of CMC and the amount of NaOH consumed by the CMC solution to pH 5 was recorded 
as Vb. The following formula was subsequently used to determine the aldehyde content in 
DCMC. 
 
Equation 1 
In Equation 1, 𝑴𝑵𝒂𝑶𝑯 is the Molarity of the sodium hydroxide solution, m is the mass of 
the oxidized material used and 211 g/mol is the average molecular weight of the repeating unit. 
The equation is divided by a factor of two because a dialdehyde is created when the repeating 
unit is modified. 
 
5.4 Hydrogel formulation  
When tested for gelation, the MeDCMC reacted for one day was unable to polymerize 
𝑨𝒍𝒅𝒆𝒉𝒚𝒅𝒆 𝑪𝒐𝒏𝒕𝒆𝒏𝒕 =
𝑴𝑵𝒂𝑶𝑯(𝑽𝒄 − 𝑽𝒃)/𝟐
𝒎/𝟐𝟏𝟏
 × 𝟏𝟎𝟎% 
Figure 5-3. Double Barrel Syringe with Mixing Tip 
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when mixed with MeCMCLV1, therefore all subsequent batches were methacrylated for three 
days. MeDCMC and MeCMC were weighed out and placed in both barrels of a double barrel 
syringe. An appropriate amount of 1X Dulbecco’s phosphate-buffered saline (DPBS) 
(Invitrogen) was added to each barrel to bring the solution to the proper concentration, and the 
solution was manually stirred with a metal rod and dissolved at 37°C for several hours with 
intermittent mixing to obtain a homogenous maximally dissolved solution. The solutions were 
stirred immediately after preparation and placed on ice in a 4°C refrigerator overnight. The next 
day the redox initiators APS (25 mM) (Sigma-Aldrich) and TEMED (25 mM) (Sigma-Aldrich) 
were added to separate barrels, well incorporated to the viscous solutions via stirring, and heated 
to 37°C in a water bath for approximately 30 minutes to 1 hour until the lap shear testing 
samples were prepared. A mixer tip was then attached to the double barrel apparatus and the 
sample was extruded for mechanical testing. 
 
5.5 Lap Shear Testing 
      Lap shear tests are commonly used as a method of determining the adhesive strength for 
materials that bond biological tissues 
41,69
. In this study, porcine dermis was chosen as the 
Figure 5-4. Custom built PVC casting devices 
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biological substrate for adhesion because of its uniformity and availability. Porcine tissue, 
excised from the back of the animal, was purchased from a local market. The samples were 
manually cleaned of all fatty tissue leaving only the residual dermal tissue and they were frozen 
at 20°C. Frozen samples were cut into 8mm in diameter rounds using a biopsy punch and 
samples were thawed and placed in a 1XPBS solution (Sigma) overnight. Strips of sandpaper 
approximately 3.5 cm in length and 1cm width were cut and the porcine dermis was glued via 
Loctite Super Glue (Henkel Corp., Rocky Hill, CT). The use of sandpaper assured that the 
adhesive was only capable of adhering the porcine skin and only the defined contact area. The 
use of strips of overlapped porcine skin in pilot studies resulted in non-uniformities with regards 
to contact area, thus a circular construct with a non-biological backing was chosen. The porcine 
samples were then glued to the smoother paper side of the sandpaper with the epidermis facing 
up and the contact area was photographed using a stereomicroscope prior to testing. The samples 
were then placed in PVC casting device and one strip was secured via a clamp. The polymer 
solution was then applied to the porcine skin and the other round of skin on the sandpaper strip 
was precisely placed over the first to maximize contact area and clamped down to ensure that the 
layers did not move. The samples were then placed in a humidified incubator at 37°C and 
allowed to cure for one hour. Adhesion was assessed by a lap shear test using an Instron Series 
5543 (Canton, MA) equipped with a 10N load cell. The upper grip moved upwards at a speed of 
5 mm/min at room temperature to measure the adhesive shear strength (Figure 5-6). Studies 
involving experimental bioadhesives used crosshead speeds ranging from 5 mm/min to 
10mm/min
41,43,48
. Additionally, preliminary testing with dual-modified CMC showed that a 
crosshead speed 5mm/min was suitable for the measurement of the adhesive strength. The 
samples were loaded until failure and 8 samples were used for each formulation. All of the 
materials synthesized were tested to see if they were inherently adhesive and in combinations 
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which are shown in Figure 5-5.  The combinations were tested in various ratios to try to optimize 
injectability and gelation. 
Figure 5-5. Formulations of CMC Investigated  
 
Sample CMCMV DCMCMV DCMCHV MeCMCLV MeCMCMV MeDCMCMV MeDCMCHV
CMCMV CMCMV
DCMCMV Not Tested DCMCMV
DCMCHV Not Tested Not Tested DCMCHV
MeCMCLV Not Tested Tested Tested MeCMCLV
MeCMCMV Not Tested Not Tested Not Tested Not Tested MeCMCMV
MeDCMCMV Not Tested Not Tested Not Tested Tested Not Tested MeDCMCMV
MeDCMCHV Not Tested Not Tested Not Tested Tested Tested Not Tested MeDCMCHV
Figure 5-6. Sample before (left) and after (right) shear adhesive testing at a head speed of 
5mm/min 
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5.6 Size Exclusion Chromatography - Multi-Angle Light Scattering (SEC-MALS) Sample 
Preparation 
 SEC-MALS experiments were carried out using a DAWN HELEOS MALS detector 
(Wyatt Technology, Santa Barbara, USA) with a laser wavelength of 658.0 nm. To prepare 
samples for SEC-MALS 10 ml of a 1g/L solution of MeDCMC was dissolved in 100 mMol/L 
solution of sodium chloride as carried out by Hoogendam et al
70
. Previous experiments involving 
SEC-MALS showed that CMC in pure diH2O was interacting with the column, thus the addition 
of a 100 mMol/L solution of sodium chloride as the eluent showed that the solvent was suitable 
for the SEC. The injection loop volume was 100 µl and the volumetric flow rate was 1mL/min. 
Data acquisition and analysis was performed using Astra Version 5.3.4.20. The dispersity index 
(Đ) is the measure of how uniformly distributed the molecular masses are within a sample71. 
Dispersity is the ratio of the weight average molecular weight to the number-average molecular 
weight as shown in Equation 2.  
Đ𝑴  =  
𝑴𝒘
𝑴𝒏
 
Equation 2 
5.7 Statistical Analysis 
 A one-way ANOVA with a Tukey’s post-hoc test was used to determine the effect of the 
ratio of MeDCMC to MeCMC on the adhesive shear strength (P < 0.05). Data represent the 
mean ± STD. 
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Chapter 6 : Results and Discussion 
6.1 Characterization of CMC derivatives 
MeDCMCMV and MeDCMCHV were synthesized via the oxidation of the C2, C3 bond 
and the esterification of unreacted hydroxyl groups with methacrylic anhydride. Representative 
NMR spectra of MeDCMC (Figure 6-1. & Figure 6-2.) and MeCMC (Figure 6-3.) samples show 
the characteristic methacrylate peaks (methyl peak at 1.9 ppm and methylene peaks at 5.8 & 6.2 
ppm) and the characteristic aldehyde peak (9.0 ppm). The methacrylation percentage of the 
MeDCMCHV2 sample used in the lap shear testing study was determined to be ~ 49% and the 
methacrylation of the MeCMCLV1 was determined to be ~ 31%. The methacrylation percentage 
was calculated by comparing the relative area of the methyl peak and the area of the backbone 
peak to their respective number of hydrogens (Equation 3). 
 
Equation 3 
 
A high degree of methacrylation is necessary, as increased methacrylation decreases the 
gelation time and increases the cohesive potential of the material. Given the high degree of 
methacrylation, the material should have formed gels at concentrations upwards of 1% if the 
molecular weight of the polymer was unchanged. However, later studies involving the 
characterization of the Đ and Mw of the MeDCMC via SEC-MALS showed the presence of 
drastically degraded polymer that may have impeded the formation of cohesive gels. This result 
was most likely due to random chain scission via sodium periodate and the β-elimination during 
the methacrylation reaction in alkaline conditions
60–63
. 
 
 ( 𝑀𝑒𝑡ℎ𝑦𝑙 𝑃𝑒𝑎𝑘 𝐴𝑟𝑒𝑎)/(# 𝑜𝑓 𝑝𝑟𝑜𝑡𝑜𝑛𝑠 𝑖𝑛 𝑀𝑒𝑡ℎ𝑦𝑙) 
 (𝐵𝑎𝑐𝑘𝑏𝑜𝑛𝑒 𝐴𝑟𝑒𝑎)/(# 𝑜𝑓 𝑝𝑟𝑜𝑡𝑜𝑛𝑠 𝑖𝑛 𝑏𝑎𝑐𝑘𝑏𝑜𝑛𝑒) 
𝑥100 = % 𝑀𝑜𝑑𝑖𝑓𝑖𝑐𝑎𝑡𝑖𝑜𝑛 
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Figure 6-1. NMR Spectrum of MeDCMCMV2 
 
Figure 6-2. NMR Spectrum of MeDCMCHV2 
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Figure 6-3. NMR Spectrum of MeCMCLV1 
6.2 Determination of Aldehyde Content 
Previously, sodium periodate oxidized batches of CMCMV resulted in oxidation 
percentages over 40% (MeDCMCMV2). While it was the intention to maximize the oxidation to 
achieve maximal adhesion with the least amount of polymer, it resulted in a polymer that was 
mechanically compromised.  This assessment was made visually and via manual manipulation of 
the material. Thus, for experiments involving adhesive testing, the high molecular weight 
polymer was chosen as the starting material, as it was thought to be sufficiently large enough to 
withstand the degradative effects of the oxidation and methacrylation process, and retain a 
fraction of polymer with a large molecular weight. Additionally, ethanol was added to quench 
the later reactions in order to ensure that the sodium periodate was inactivated. This ethanol 
quenching was not performed on the MeDCMCMV2 material and the results show that these two 
actions resulted in a significantly less oxidized polymer (20%, as assessed by Schiff base 
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titration). Future studies involving the dual modification of CMC should investigate how 
prolonged methacrylation and oxidation reactions affect the molecular weight of the product 
such that the proper steps can be taken to reduce the degradation of the polymer and optimize the 
purification and homogeneity of the polymer. One step that can be taken immediately is the use 
of a larger molecular weight cutoff for dialysis. The molecular weight cutoff for the dialysis 
tubing used in all of these reactions was 6-8 kDa, which may retain a significant amount of the 
oxidized polymer but contribute to a non-uniform highly polydisperse sample. The gelation rate 
of a polymer is contingent on the mobility of the polymer and the entanglement density in 
solution
72
. The formation of a 3D network is therefore highly dependent on the dispersity of a 
material. The presence of smaller the fragments may lower the probability of interchain 
association, thereby decreasing the rate of gel formation. Pilot studies involving porcine samples 
incubated for 24 hours showed that gel formation eventually occurred but the time elapsed did 
not meet the criteria for a material to be a clinically relevant bioadhesive.  
 
6.3 Analysis of Adhesive Strength 
 Various solutions were tested to show how the various ratios of dual-modified CMC and 
methacrylated CMC affected the adhesive strength of the material. Over the course of developing 
Figure 6-4 Table of all combinations tested *Unable to surpass Instron threshold for measurement (Qualitative 
Assessment) 
Sample CMCMV DCMCMV DCMCHV MeCMCLV MeCMCMV MeDCMCMV MeDCMCHV
CMCMV CMCMV
DCMCMV Not Tested DCMCMV
DCMCHV Not Tested Not Tested DCMCHV
MeCMCLV Not Tested Failed Failed MeCMCLV
MeCMCMV Not Tested Not Tested Not Tested Not Tested MeCMCMV
MeDCMCMV Not Tested Not Tested Not Tested Failed Not Tested MeDCMCMV
MeDCMCHV Not Tested Not Tested Not Tested Success Success* Not Tested MeDCMCHV
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these materials, different combinations were explored at various ratios for adhesivity, including 
DCMC alone, MeCMC + DCMC, MeDCMC + MeCMC, and MeCMC. No material alone was 
sufficiently adhesive to attach to tissues.  The only combination of materials that was able to 
form an adhesive gel was MeDCMCHV +MeCMCLV. MeDCMCHV + MeCMCMV was strong 
enough to load materials for testing, however, the material did not reach the minimum force 
threshold for accurate measurement on the Instron. 
The rationale for creating the MeDCMCHV-MeCMCLV mix was based on the idea that 
MeCMC would serve to increase the cohesion of the gels and the MeDCMC would act as the 
adhesive agent with the potentially cohesive functionality, capable of binding to the MeCMC, 
MeDCMC, and the tissue. The first solution was made at 30% MeDCMC and 7.5% MeDCMC 
and the remaining solutions were 40% solutions with varying ratios of MeDCMC to MeCMC as 
seen in Table 6.1.  
 
 
Solution MeDCMCHV2 % (w/v) MeCMCLV1 % (w/v) Total Polymer % (w/v) Shear Tensile Strength Pa 
(STD) 
4:1 Mix 30 7.5 37.5 4423 ± (1310) 
3:1 Mix 30 10 40 4465 ± (1477) 
5:3 Mix 25 15 40 6022 ± (1456) 
1:1 Mix 20 20 40 2971 ± (1351) 
3:5 Mix 15 25 40 2206 ± (1114) 
 
Table 6-1. Compositons of MeDCMC-MeCMC Solutions 
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There was a clear decrease in the mixibility and injectability of the material as the 
percentage of MeDCMC increased. A 30 mg/mL solution of MeDCMCHV2 alone could be easily 
mixed and injected, however, the inability to polymerize at a 25 mM initator concentration in the 
allotted time of 1 hour, and the inability to remain localized at the injection site led to the 
addition of MeCMCLV1. The adjustment of the MeDCMCHV2 concentration to 25% w/v and 
addition of MeCMCLV1 at 15% w/v in the 5:3 mix led to a polymer that had the highest mean 
adhesion strength of 6.02 ±1.46 kPa compared to the other solutions, especially the 1:1 and 3:5 
mix. According to the literature, fibrin-based sealants in lap shear adhesive tests with porcine 
epidermis produced similar values of approximately 3-8 kPa
45,73
. It is worth noting that unlike 
most adhesives, the samples failed cohesively and not at the tissue-adhesive interface. This 
suggests that a more cohesive material should be able to increase the adhesive shear strength of 
* 
a 
a $ 
b 
b b 
Figure 6-5. Adhesive strength of selected ratios of MeDCMC to MeCMC. 
Significance set at p<0.05. * significantly different than a. $
 
significantly different than b. 
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the material, and that this experiment likely measured the cohesive ability of these materials 
instead of the true adhesive capacity. The range of adhesive shear strengths of commerically 
available materials on porcine skin range from the 3 kPa in the fibrin-based adhesive Tisseel
45
 to 
200 kPa with the cyanoacrylate-based adhesive, Dermabond. The 1:1 and 3:5 mix solutions were 
extremely difficult to extrude through the mixing tip and gelled extremely quickly, therefore, 
further studies should not incorporate such viscous material at such a high concentration. Due to 
the gross amount of material needed to run each combination and the limited amount of time to 
complete the project, we were unable to test other combinations. The 49% methacrylation of the 
MeDCMCHV and the 31% methacrylation of the MeCMCLV mostly likely played a role in the 
cohesion, however, the lack of gelation of MeDCMC is an issue that must be addressed in future 
studies.  
 
6.4 Determination of Mw by SEC-MALS 
Given the time limitations of this project, the molar masses of CMC and MeDCMC in 
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Figure 6-6. Raw light scattering and Molar mass as a function  
of time as determined by SEC-MALS 
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100 mMol/L were determined using a dn/dc value of 0.156 which is an number based on 
literature that previously characterized solutions of CMC of varying degrees of substitution
70,74
. 
A use of a 100 mMol/L aqueous solution of NaCl as the solvent was show to be suitable for the 
determination of molecular weights of CMC and MeDCMC. There is a clear trend in the 
distribution of molar masses in samples that double-modified polymer compared to the 
unmodified CMC. Based on the nature of the elution curve (light scattering) in Figure 6-6a,b, 
unmodified CMC is monodisperse as it has smaller range of molar masses in comparison to 
MeDCMCMV2 & MeDCMCHV2 in Figure 6-6c,d, which have elution curves with a long tail and a 
wider distribution of molecular masses. The confirmation of these fragments via molar mass 
distribution analyses in Figure 6-7 and Figure 6-8 support the hypothesis that the dispersity of 
these materials were greatly affected by the dual modification process. Figure 6-9 and Figure 6-
10 show the molar mass distribution between two molecular weights of MeDCMC. The molar 
mass weight fraction of MeDCMCMV2 shows that only 35.37% of the molecules are larger than 
50 kDa, which is significantly less when compared to the 64.49% of the molecular weight 
greater than 50 kDa retained by MeDCMCHV2. This reinforces the idea that further steps can be 
taken to purify MeDCMCHV such that it is monodisperse without a severe loss in the overall 
yield of the reaction. Given that the molecular weight of the largest molecules that eluted from 
each sample were larger than the advertised molecular weight of the material, this suggests the 
formation of aggregates, which may affect the true distribution of the molecular weight. The 
presence of these aggregates also introduces error into the calculation of Đ (Table 6-2). To help 
reduce the formation of aggregates, the solutions may be prepared under constant agitation as to 
detangle and prevent the formation of aggregates. The sodium chloride and polymer 
concentration in solution also play a major role in aggregate formation; therefore, it is necessary 
to test these parameters in the future. 
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Figure 6-7. Molar Mass Distribution Analysis of Unmodified Low Viscosity CMC 
 
 
 
 
Figure 6-8. Molar Mass Distribution Analysis of Unmodified High Viscosity CMC  
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Figure 6-10. Molar Mass Distribution Analysis of MeDCMCHV2 
Figure 6-9. Molar Mass Distribution Analysis of MeDCMCMV2 
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Material Mw (g/mol) Mn (g/mol) Dispersity Index (Đ) 
CMCLV 2.2510E+05 1.4830E+05 1.52 
CMCHV 1.0130E+06 8.9160E+05 1.14 
MeDCMCMV 1.0670E+05 3.6270E+04 2.94 
MeDCMCHV 1.0840E+05 5.6060E+04 1.93 
Table 6-2. Calculated values of Mw, Mn, and the resulting Đ. The Đ of MeDCMCMV was 
significantly higher than all of the other materials, as predicted by the visual assessment of the 
lyophilized polymer and the shape of the elution curve. 
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Conclusions 
 Dual-modified carboxymethylcellulose was created via sodium periodate oxidation and 
the esterification of hydroxyl groups to add methacrylate groups. The Schiff Base reaction with 
hydroxylamine hydrochloride and titration of HCl with NaOH was used to assess the percent 
oxidation. The successful addition of methacrylate groups was assessed via NMR spectroscopy. 
The inability of MeDCMC to form a cohesive gel led to the addition of a methacrylated low 
viscosity CMC as a cohering agent. Various ratios of MeDCMCHV to MeCMCLV were tested and 
the lap shear adhesive strength was affected by the ratio of MeDCMCHV to MeCMCLV. In order 
to understand how dual modification of the polymer was affected, SEC-MALS was performed to 
determine the molecular weight distribution. The results showed that the molecular weight of 
CMC was significantly affected by the dual modification, which mostly likely produced the 
inferior gelation capability. Gelation optimization will vastly improve the ability for MeDCMC 
to seal an AF defect. Qualitative studies with robustly gelling solutions of MeDCMC 
polymerized with 250 mM redox initiator concentration showed that the adhesive potential on 
porcine skin was substantial. However this initiator concentration is likely to cause damage to 
nearby cells and tissues. 
 CMC shows promise as a base material for bioadhesive applications because of its ability 
to be readily oxidized and methacrylated. The suggestions for the optimization of the dispersity 
should increase the likelihood that a monodisperse material can be extracted from the reaction, 
which increases the likelihood of the development of an adhesive that can form a cohesive 
material without the addition of MeCMC. Given the susceptibility of oxidized cellulose to 
alkaline β-elimination, there may be a valid argument for reversing the order of the reactions and 
oxidizing CMC after methacrylation. The methacrylation of CMC is optimal in basic conditions 
and requires a total of 5-6 days in water, which may result in severe degradation to the backbone.  
41 
 
The addition of a peptide such as poly (l-lysine) could be beneficial to the formation of a 
cohesive material that has a dual-crosslinking mechanism. Having two means of crosslinking 
should also allow for lower macromer concentrations, and thus improve the injectability of the 
material and its likelihood as an AF sealant. 
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Future Directions 
Future work concerning the development of a bioadhesive using MeDCMC will require 
the optimization of the protocol. By extending the time for dialysis against diH2O as well as 
using a larger molecular weight cutoff we can decrease the polydispersity of the material leading 
to a more uniform material with more predictable gelation characteristics. Additionally, 
cytotoxicity studies should be performed in order to observe the cellular response to the aldehyde 
moieties on the CMC backbone. Cytotoxicity studies should involve the cellular response to 
encapsulation as well as indirect and direct contact. Once the material is monodisperse, 
degradation studies should also be performed to see how crosslinked hydrogels composed of 
MeDCMC degrade compared to solutions of MeCMC of similar molecular weight and 
methacrylation. A one-component system consisting of solely MeDCMC is ideal because it 
introduces fewer variables. However, the addition of MeCMC may serve to dilute the adhesive 
effects of a highly oxidized polymer, and a highly methacrylated formulation could further 
increase the cohesive strength of the material. Swelling tests should also be conducted to 
determine the response of the material to an aqueous environment, in vitro and in vivo, once the 
material is deemed cytocompatible. 
The degree of oxidation of CMC via sodium periodate can be altered by the sodium 
periodate concentration, the length of the reaction, and the use of an alcohol to quench the 
reaction. Therefore, future studies should investigate how a lengthened reaction time can affect 
the dispersity and the degree of oxidation of CMC. The creation of a single component, 50% 
oxidized MeDCMC bioadhesive will most likely lead to the improvement of shear adhesive 
strength and cohesiveness. The cohesiveness of the material can be assessed visually by 
observing if the adhesives mechanically fail at the tissue or internally. The cohesiveness can also 
be assessed via measuring the tensile strength in response to stretch.  Additionally, this material 
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should be tested as a sealant when used in conjunction with a MeCMC hydrogels for NP 
replacement. First, a push-out test should be performed with a circular defect in annular tissue to 
determine if the material is able to properly integrate into the AF, and secondly, a tissue explant 
model using bovine caudal discs under dynamic loading should be employed to determine if 
MeDCMC is capable of containing engineered NP material within the disc space under 
physiological loading conditions. Comparison to commercially available sealants and biological 
glues under identical testing conditions would also be necessary to confirm the utility of this 
novel, cellulose-based adhesive.  
  
44 
 
Acknowledgements 
 First I would like to thank my thesis advisor, Dr. Steven B. Nicoll for taking me in and 
giving me the opportunity to pursue my Master’s degree in Biomedical Engineering in his 
Connective Tissue Engineering Laboratory. I would also like to thank the Department of 
Biomedical Engineering for accepting me into the program and believing in my ability to 
conduct research. The tight-knit community of scholarship and research in the Biomedical 
Engineering Department at the City College of New York has helped me discover that I would 
like to partake in knowledge creation. 
I will always appreciate how fortunate I was to find such amazing lab mates such as 
Devika Varma, Gittel Gold, Anna Lin, Nada Haq-Siddiqi, and Dr. Michelle DiNicolas. Words 
cannot express how thankful I am for your constant support, advice, and training that has molded 
me into a stronger researcher and a better person. I would also like to acknowledge Dr. 
Padmanava Pradhan for teaching me how to use the NMR and decode spectra, Dr. Raymond Tu 
and Lake Kubilius for assisting me in the SEC-MALS analysis on my materials, and my 
committee members Dr. Sihong Wang and Dr. Debra Auguste. 
These last two years could have not been possible without the unwavering love and 
support from my mother Michael Vallery and my girlfriend Jessica Patterson. They often say 
that behind every great man is a great woman. I believe that my possibilities are endless because 
I have two great women on my side.  
  
45 
 
References 
1.  Chan SCW, Gantenbein-Ritter B. Intervertebral disc regeneration or repair with 
biomaterials and stem cell therapy--feasible or fiction? Swiss Med Wkly. 2012;142(May 
2012):w13598. doi:10.4414/smw.2012.13598. 
2.  Adams MA, Stefanakis M, Dolan P. Clinical Biomechanics Healing of a painful 
intervertebral disc should not be confused with reversing disc degeneration : Implications 
for physical therapies for discogenic back pain. JCLB. 2010;25(10):961-971. 
doi:10.1016/j.clinbiomech.2010.07.016. 
3.  Rannou F, Mayoux-Benhamou MA, Poiraudeau S, Revel M. Disque intervertébral et 
structures voisines de la colonne lombaire: Anatomie, biologie, physiologie et 
biomécanique. EMC-Rhumatologie-Orthopedie. 2004;1(6):487-507. 
doi:10.1016/j.emcrho.2003.11.007. 
4.  Iatridis JC, Setton L a, Foster RJ, Rawlins B a, Weidenbaum M, Mow VC. Degeneration 
affects the anisotropic and nonlinear behaviors of human anulus fibrosus in compression. 
J Biomech. 1998;31(6):535-544. http://www.ncbi.nlm.nih.gov/pubmed/9755038. 
5.  Wagner DR, Reiser KM, Lotz JC. Glycation increases human annulus fibrosus stiffness in 
both experimental measurements and theoretical predictions. J Biomech. 2006;39(6):1021-
1029. doi:10.1016/j.jbiomech.2005.02.013. 
6.  Iatridis JC, Nicoll SB, Michalek AJ, Walter BA, Gupta MS. Role of biomechanics in 
intervertebral disc degeneration and regenerative therapies : what needs repairing in the 
disc and what are promising biomaterials for its repair ? Spine J. 2013;13(3):243-262. 
doi:10.1016/j.spinee.2012.12.002. 
7.  Waterman BR, Belmont PJ, Schoenfeld AJ. Low back pain in the United States : 
incidence and risk factors for presentation in the emergency setting. Spine J. 
2012;12(1):63-70. doi:10.1016/j.spinee.2011.09.002. 
8.  Becker A, Held H, Redaelli M, et al. Low back pain in primary care: costs of care and 
prediction of future health care utilization. Spine (Phila Pa 1976). 2010;35(18):1714-
1720. doi:10.1097/BRS.0b013e3181cd656f. 
9.  McGrory JE, Guyer RD. Lumbar fusion: A defensible option for discogenic low back 
pain? Semin Spine Surg. 2011;23(4):227-234. doi:10.1053/j.semss.2011.05.003. 
10.  Mirza SK, Deyo RA, Heagerty PJ, Turner JA, Martin BI, Comstock BA. One-year 
outcomes of surgical versus nonsurgical treatments for discogenic back pain: A 
community-based prospective cohort study. Spine J. 2013;13(11):1421-1433. 
doi:10.1016/j.spinee.2013.05.047. 
46 
 
11.  Petersohn JD. Advances in biological techniques for treatment of lumbar discogenic pain. 
Tech Reg Anesth Pain Manag. 2013;16(2):89-94. doi:10.1053/j.trap.2013.02.003. 
12.  Adams M a, McNally DS, Dolan P. “Stress” distributions inside intervertebral discs. The 
effects of age and degeneration. J Bone Joint Surg Br. 1996;78(6):965-972. 
13.  Michalek AJ, Buckley MR, Bonassar LJ, Cohen I, Iatridis JC. The effects of needle 
puncture injury on microscale shear strain in the intervertebral disc annulus fibrosus. 
Spine J. 2010;10(12):1098-1105. doi:10.1016/j.spinee.2010.09.015. 
14.  Reza AT, Nicoll SB. Serum-free, chemically defined medium with TGF-beta(3) enhances 
functional properties of nucleus pulposus cell-laden carboxymethylcellulose hydrogel 
constructs. Biotechnol Bioeng. 2010;105(2):384-395. doi:10.1002/bit.22545. 
15.  Strange DGT, Oyen ML. Composite hydrogels for nucleus pulposus tissue engineering. J 
Mech Behav Biomed Mater. 2012;11:16-26. doi:10.1016/j.jmbbm.2011.10.003. 
16.  Roughley P, Hoemann C, DesRosiers E, Mwale F, Antoniou J, Alini M. The potential of 
chitosan-based gels containing intervertebral disc cells for nucleus pulposus 
supplementation. Biomaterials. 2006;27(3):388-396. 
doi:10.1016/j.biomaterials.2005.06.037. 
17.  Su WY, Chen YC, Lin FH. Injectable oxidized hyaluronic acid/adipic acid dihydrazide 
hydrogel for nucleus pulposus regeneration. Acta Biomater. 2010;6(8):3044-3055. 
doi:10.1016/j.actbio.2010.02.037. 
18.  Spotnitz WD, Burks S. Hemostats, sealants, and adhesives: components of the surgical 
toolbox. Transfusion. 2008;48(July):1502-1516. doi:10.1111/j.1537-2995.2008.01703.x. 
19.  Wilson YL, Ellis D a F. Permanent soft tissue fillers. Facial Plast Surg. 2011;27:540-546. 
doi:10.1055/s-0031-1298787. 
20.  Singer AJ, Mach C, Thode HC, Hemachandra S, Shofer FS, Hollander JE. Patient 
priorities with traumatic lacerations. Am J Emerg Med. 2000;18(6):683-686. 
doi:10.1053/ajem.2000.16312. 
21.  Spotnitz WD, Burks S. Hemostats, sealants, and adhesives III: A new update as well as 
cost and regulatory considerations for components of the surgical toolbox. Transfusion. 
2012;52(October):2243-2255. doi:10.1111/j.1537-2995.2012.03707.x. 
22.  Yag-Howard C. Sutures, Needles, and Tissue Adhesives. Dermatologic Surg. 2014;40:S3-
S15. doi:10.1097/01.DSS.0000452738.23278.2d. 
23.  Tajirian AL, Goldberg DJ. A review of sutures and other skin closure materials. J Cosmet 
Laser Ther. 2010;12(August):296-302. doi:10.3109/14764172.2010.538413. 
47 
 
24.  García-Gubern CF, Colon-Rolon L, Bond MC. Essential Concepts of Wound 
Management. Emerg Med Clin North Am. 2010;28(4):951-967. 
doi:10.1016/j.emc.2010.06.009. 
25.  Chiang C-J, Cheng C-K, Sun J-S, Liao C-J, Wang Y-H, Tsuang Y-H. The effect of a new 
anular repair after discectomy in intervertebral disc degeneration: an experimental study 
using a porcine spine model. Spine (Phila Pa 1976). 2011;36(10):761-769. 
doi:10.1097/BRS.0b013e3181e08f01. 
26.  Chiang YF, Chiang CJ, Yang CH, et al. Retaining intradiscal pressure after annulotomy 
by different annular suture techniques, and their biomechanical evaluations. Clin Biomech. 
2012;27(3):241-248. doi:10.1016/j.clinbiomech.2011.09.008. 
27.  Azadani AN, Matthews PB, Ge L, et al. Mechanical Properties of Surgical Glues Used in 
Aortic Root Replacement. Ann Thorac Surg. 2009;87(4):1154-1160. 
doi:10.1016/j.athoracsur.2008.12.072. 
28.  Vuocolo T, Haddad R, Edwards GA, et al. A Highly Elastic and Adhesive Gelatin Tissue 
Sealant for Gastrointestinal Surgery and Colon Anastomosis. J Gastrointest Surg. 
2012;16(4):744-752. doi:10.1007/s11605-011-1771-8. 
29.  Martinez-De-La-Casa JM, Rayward O, Saenz-Frances F, Mendez C, Bueso ES, Garcia-
Feijoo J. Use of a fibrin adhesive for conjunctival closure in trabeculectomy. Acta 
Ophthalmol. 2013;91(5):425-428. doi:10.1111/j.1755-3768.2012.02436.x. 
30.  Park EL, Ulreich JB, Scott KM, et al. Evaluation of polyethylene glycol based hydrogel 
for tissue sealing after laparoscopic partial nephrectomy in a porcine model. J Urol. 
2004;172(6 Pt 1):2446-2550. doi:10.1097/01.ju.0000138159.69642.d9. 
31.  Bernie JE, Ng J, Bargman V, Gardner T, Cheng L, Sundaram CP. Evaluation of hydrogel 
tissue sealant in porcine laparoscopic partial-nephrectomy model. J Endourol. 
2005;19(9):1122-1126. doi:10.1089/end.2005.19.1122. 
32.  Spotnitz WD, Burks S. State-of-the-art review: Hemostats, sealants, and adhesives II: 
Update as well as how and when to use the components of the surgical toolbox. Clin Appl 
Thromb Hemost. 2010;16(5):497-514. doi:10.1177/1076029610363589. 
33.  Pursifull NF, Morey AF. Tissue glues and nonsuturing techniques. Curr Opin Urol. 
2007;17:396-401. doi:10.1097/MOU.0b013e3282f0d683. 
34.  Mehdizadeh M, Yang J. Design Strategies and Applications of Tissue Bioadhesives. 
Macromol Biosci. 2013;13(3):271-288. doi:10.1002/mabi.201200332. 
35.  Spotnitz WD. Efficacy and safety of fibrin sealant for tissue adherence in facial 
rhytidectomy. Clin Cosmet Investig Dermatol. 2012;5:43-51. doi:10.2147/CCID.S25747. 
48 
 
36.  Hino M, Ishiko O, Honda KI, et al. Transmission of symptomatic parvovirus B19 
infection by fibrin sealant used during surgery. Br J Haematol. 2000;108(1):194-195. 
doi:10.1046/j.1365-2141.2000.01818.x. 
37.  Buchta C, Dettke M, Funovics PT, et al. Fibrin sealant produced by the CryoSeal® FS 
System: Product chemistry, material properties and possible preparation in the autologous 
preoperative setting. Vox Sang. 2004;86(2004):257-262. doi:10.1111/j.0042-
9007.2004.00516.x. 
38.  Hoffmann B, Volkmer E, Kokott A, et al. Characterisation of a new bioadhesive system 
based on polysaccharides with the potential to be used as bone glue. J Mater Sci Mater 
Med. 2009;20(10):2001-2009. doi:10.1007/s10856-009-3782-5. 
39.  Garcia-Roig M, Gorin MA, Castellan M, Ciancio G. OMNEX surgical sealant in the 
extracorporeal repair of renal artery aneurysms. Ann Vasc Surg. 2011;25(8):1141.e5-e8. 
doi:10.1016/j.avsg.2011.07.009. 
40.  Fürst W, Banerjee A. Release of glutaraldehyde from an albumin-glutaraldehyde tissue 
adhesive causes significant in vitro and in vivo toxicity. Ann Thorac Surg. 2005;79:1522-
1528. doi:10.1016/j.athoracsur.2004.11.054. 
41.  Wang T, Nie J, Yang D. Dextran and gelatin based photocrosslinkable tissue adhesive. 
Carbohydr Polym. 2012;90(4):1428-1436. doi:10.1016/j.carbpol.2012.07.011. 
42.  Matsumura K, Nakajima N, Sugai H, Hyon SH. Self-degradation of tissue adhesive based 
on oxidized dextran and poly-l-lysine. Carbohydr Polym. 2014;113:32-38. 
doi:10.1016/j.carbpol.2014.06.073. 
43.  Hyon SH, Nakajima N, Sugai H, Matsumura K. Low cytotoxic tissue adhesive based on 
oxidized dextran and epsilon-poly- l -lysine. J Biomed Mater Res - Part A. 
2014;102:2511-2520. doi:10.1002/jbm.a.34923. 
44.  Balakrishnan B, Joshi N, Jayakrishnan A, Banerjee R. Self-crosslinked oxidized 
alginate/gelatin hydrogel as injectable, adhesive biomimetic scaffolds for cartilage 
regeneration. Acta Biomater. 2014;10(8):3650-3663. doi:10.1016/j.actbio.2014.04.031. 
45.  Jeon O, Samorezov JE, Alsberg E. Single and dual crosslinked oxidized methacrylated 
alginate/PEG hydrogels for bioadhesive applications. Acta Biomater. 2014;10:47-55. 
doi:10.1016/j.actbio.2013.09.004. 
46.  Wang D, Varghese S, Sharma B, et al. Multifunctional chondroitin sulphate for cartilage 
tissue-biomaterial integration. Nat Mater. 2007;6(5):385-392. doi:10.1038/nmat1890. 
47.  Szpak P. Fish bone chemistry and ultrastructure: Implications for taphonomy and stable 
isotope analysis. J Archaeol Sci. 2011;38(12):3358-3372. doi:10.1016/j.jas.2011.07.022. 
49 
 
48.  Serrero A, Trombotto S, Bayon Y, Gravagna P, Montanari S, David L. Polysaccharide-
based adhesive for biomedical applications: Correlation between rheological Behavior and 
Adhesion. Biomacromolecules. 2011;12:1556-1566. doi:10.1021/bm101505r. 
49.  Takagi K, Araki M, Fukuoka H, et al. Novel powdered anti-adhesion material: Preventing 
postoperative intra-abdominal adhesions in a rat model. Int J Med Sci. 2013;10(4):467-
474. doi:10.7150/ijms.5607. 
50.  Lou W, Zhang H, Ma J, et al. In vivo evaluation of in situ polysaccharide based hydrogel 
for prevention of postoperative adhesion. Carbohydr Polym. 2012;90(2):1024-1031. 
doi:10.1016/j.carbpol.2012.06.037. 
51.  Schek RM, Michalek AJ, Iatridis JC. Genipin-crosslinked fibrin hydrogels as a potential 
adhesive to augment intervertebral disc annulus repair. Eur Cells Mater. 2011;21:373-383. 
doi:10.1016/j.biotechadv.2011.08.021.Secreted. 
52.  Likhitpanichkul M, Dreischarf M, Illien-Junger S, et al. Fibrin-genipin adhesive hydrogel 
for annulus fibrosus repair: Performance evaluation with large animal organ culture, in 
situ biomechanics, and in vivo degradation tests. Eur Cells Mater. 2014;28:25-38. 
53.  Li H, Wu B, Mu C, Lin W. Concomitant degradation in periodate oxidation of 
carboxymethyl cellulose. Carbohydr Polym. 2011;84(2011):881-886. 
doi:10.1016/j.carbpol.2010.12.026. 
54.  Gupta MS, Cooper ES, Nicoll SB. Transforming Growth Factor-Beta 3 Stimulates 
Cartilage Matrix Elaboration by Human Marrow-Derived Stromal Cells Encapsulated in 
Photocrosslinked Carboxymethylcellulose Hydrogels: Potential for Nucleus Pulposus 
Replacement. Tissue Eng Part A. 2011;17(23-24):2903-2910. 
doi:10.1089/ten.tea.2011.0152. 
55.  Gupta MS. Duration of TGF-B3 Exposure Impacts the Maturation of Human MSCs in 
Photocrosslinked Carboxymethylcellulose Hydrogels. Annu Meet Orthop Res Soc. 
2014;2015(May 2015):1145-1157. doi:10.1007/s10439-014-1179-1. 
56.  Rinaudo M. Periodate oxidation of methylcellulose: Characterization and properties of 
oxidized derivatives. Polymers (Basel). 2010;2(4):505-521. doi:10.3390/polym2040505. 
57.  Potthast A, Rosenau T, Kosma P. Analysis of oxidized functionalities in cellulose. Adv 
Polym Sci. 2006;205(1):1-48. doi:10.1007/12_099. 
58.  Kim UJ, Kuga S, Wada M, Okano T, Kondo T. Periodate oxidation of crystalline 
cellulose. Biomacromolecules. 2000;1(3):488-492. doi:10.1021/bm0000337. 
59.  Artzi N, Shazly T, Baker AB, Bon A, Edelman ER. Aldehyde-amine chemistry enables 
modulated biosealants with tissue-specific adhesion. Adv Mater. 2009;21(1 mm):3399-
3403. doi:10.1002/adma.200900340. 
50 
 
60.  Christensen BE, Aasprong E, Stokke BT. Gelation of periodate oxidised scleroglucan 
(scleraldehyde). Carbohydr Polym. 2001;46(3):241-248. doi:10.1016/S0144-
8617(00)00327-1. 
61.  Maekawa E, Koshijima T. Preparation and structural consideration of nitrogen-containing 
derivatives obtained from dialdehyde celluloses. J Appl Polym Sci. 1991;42(1):169-178. 
doi:10.1002/app.1991.070420120. 
62.  Veelaert S, de Wit D, Gotlieb KF, Verhé R. Chemical and physical transitions of periodate 
oxidized potato starch in water. Carbohydr Polym. 1997;33(2-3):153-162. 
doi:10.1016/S0144-8617(97)00046-5. 
63.  Kristiansen K a., Potthast A, Christensen BE. Periodate oxidation of polysaccharides for 
modification of chemical and physical properties. Carbohydr Res. 2010;345(10):1264-
1271. doi:10.1016/j.carres.2010.02.011. 
64.  DiZerega G, Cere S. Use of Adhesion Prevention Barriers in Pelvic Reconstructive and 
Gynecologic Surgery. In: diZerega G, ed. Peritoneal Surgery SE - 34. Springer New 
York; 2000:379-399. doi:10.1007/978-1-4612-1194-5_34. 
65.  Varma DM, Gold GT, Taub PJ, Nicoll SB. Injectable carboxymethylcellulose hydrogels 
for soft tissue filler applications. Acta Biomater. 2014;10(12):4996-5004. 
doi:10.1016/j.actbio.2014.08.013. 
66.  Gold GT, Varma DM, Harbottle D, et al. Injectable redox-polymerized methylcellulose 
hydrogels as potential soft tissue filler materials. J Biomed Mater Res A. 2014;(May):1-9. 
doi:10.1002/jbm.a.35132. 
67.  Park H, Temenoff JS, Tabata Y, Caplan AI, Mikos AG. Injectable biodegradable hydrogel 
composites for rabbit marrow mesenchymal stem cell and growth factor delivery for 
cartilage tissue engineering. Biomaterials. 2007;28(21):3217-3227. 
doi:10.1016/j.biomaterials.2007.03.030. 
68.  Head SH, Hughes G, Head FSH, Hughes G. The oxidation of simple organic substances 
by sodium metaperiodate in solutions exposed to daylight. J Chem Soc. 1952;(0):2046-
2052. doi:10.1039/JR9520002046. 
69.  McDermott MK, Chen T, Williams CM, Markley KM, Payne GF. Mechanical properties 
of biomimetic tissue adhesive based on the microbial transglutaminase-catalyzed 
crosslinking of gelatin. Biomacromolecules. 2004;5:1270-1279. doi:10.1021/bm034529a. 
70.  Hoogendam CW, de Keizer A, Cohen Stuart M a, et al. Persistence Length of 
Carboxymethyl Cellulose As Evaluated from Size Exclusion Chromatography and 
Potentiometric Titrations. Macromolecules. 1998;31(18):6297-6309. 
doi:10.1021/ma971032i. 
51 
 
71.  Gaborieau M, Castignolles P. Size-exclusion chromatography (SEC) of branched 
polymers and polysaccharides. Anal Bioanal Chem. 2011;399(4):1413-1423. 
doi:10.1007/s00216-010-4221-7. 
72.  Cui SW. Polysaccharide Gums from Agricultural Products: Processing, Structures and 
Functionality. 1st ed. Lancaster: CRC Press; 2000. 
73.  Chivers RA, Wolowacz RG. The strength of adhesive-bonded tissue joints. Int J Adhes 
Adhes. 1997;17(2):127-132. doi:10.1016/S0143-7496(96)00041-3. 
74.  Shakun M, Maier H, Heinze T, Kilz P, Radke W. Molar mass characterization of sodium 
carboxymethyl cellulose by SEC-MALLS. Carbohydr Polym. 2013;95(1):550-559. 
doi:10.1016/j.carbpol.2013.03.028.  
 
 
 
 
